[
1. Kowalski K, Jeznach A, Tuokko HA. Stages of driving behavior change within the Transtheoretical Model (TM). J Safety Res 2014; 50: 17-25.10.1016/j.jsr.2014.01.00225142357
]Search in Google Scholar
[
2. Gutierrez-Abejón E, Herrera-Gómez F, Criado-Espegel P, Alvarez FJ. Use of driving-impairing medicines by a Spanish population: a population-based registry study. BMJ Open 2017; 7(11): e017618.10.1136/bmjopen-2017-017618571931529170289
]Search in Google Scholar
[
3. Alonso F, Esteban C, Sanmartín J, Useche SA. Consistency between the subjective perception of feeling indisposed, the decision to drive and driving performance. Sci J Public Health 2016; 4(6): 482-8.10.11648/j.sjph.20160406.21
]Search in Google Scholar
[
4. Driver and Vehicle Licensing Agency. Assessing Fitness to Drive–a Guide for Medical Professionals. London: Department for transport; 2016.
]Search in Google Scholar
[
5. Haghi A, Ketabi D, Ghanbari M, Rajabi, H. Assessment of human errors in driving accidents; analysis of the causes based on aberrant behaviors. Life Sci J 2014; 11(9): 414-20.
]Search in Google Scholar
[
6. Del Río MC, Alvarez FJ. Medication and fitness to drive. Pharmacoepidemiol Drug Saf. 2003; 12(5): 389-94.10.1002/pds.80612899113
]Search in Google Scholar
[
7. Sigona N, Williams KG. Driving under the influence, public policy, and pharmacy practice. J Pharm Pract 2015; 28(1): 119-23.10.1177/089719001454983925312259
]Search in Google Scholar
[
8. Brady JE, Li G. Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010. Am J Epidemiol 2014; 179(6): 692-9.10.1093/aje/kwt327393985024477748
]Search in Google Scholar
[
9. Rudisill TM, Zhu M, Kelley GA, Pilkerton C, Rudisill BR. Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review. Accid Anal Prev 2016; 96: 255-70.10.1016/j.aap.2016.08.001504581927569655
]Search in Google Scholar
[
10. Kelly E, Darke S, Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev 2004; 23: 319-44.10.1080/0959523041233128948215370012
]Search in Google Scholar
[
11. Duquet N. Drugs and driving [Conduite et médicaments]. J Pharm Belg 2013; (2): 4-11.
]Search in Google Scholar
[
12. Verster JC, Roth T. Drivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality. Psychopharmacology 2012; 219(3): 775-81.10.1007/s00213-011-2400-7325936621750898
]Search in Google Scholar
[
13. Hetland A, Carr DB. Medications and impaired driving. Ann Pharmacother 2014; 48(4): 494-506.10.1177/1060028014520882396558124473486
]Search in Google Scholar
[
14. Kelley-Baker T, Waehrer G, Pollini RA. Prevalence of Self-Reported Prescription Drug Use in a National Sample of U.S. Drivers. J Stud Alcohol Drugs 2017; 78(1): 30-8.10.15288/jsad.2017.78.30514874727936362
]Search in Google Scholar
[
15. Walsh JM, Verstraete AG, Huestis MA, Mørland J. Guidelines for research on drugged driving. Addiction 2008; 103(8): 1258-68.10.1111/j.1360-0443.2008.02277.x269060718855814
]Search in Google Scholar
[
16. Ramaekers JG. Drugs and Driving Research in Medicinal Drug Development. Trends Pharmacol Sci 2017; 38(4): 319-21.10.1016/j.tips.2017.01.00628283199
]Search in Google Scholar
[
17. Albrecht M. The “Driving under the Influence of Drugs, Alcohol and Medicines”(DRUID) project of the European Commission. Dtsch Med Wochenschr 2008; 133 Suppl 2: S45-6.10.1055/s-2008-108107318548371
]Search in Google Scholar
[
18. European Monitoring Centre for Drugs and Drug Addiction. Driving Under the Influence of Drugs, Alcohol and Medicines in Europe — findings from the DRUID project. Luxembourg: Publications Office of the European Union; 2012.
]Search in Google Scholar
[
19. Act about road traffic safety. Official Gazette of Republic of Serbia. 2018; 24.
]Search in Google Scholar
[
20. Newnam S, Greenslade J, Newton C, Watson B. Safety in occupational driving: Development of a driver behaviour scale for the workplace context. Appl Psychol- Int Rev 2011; 60: 576–99.10.1111/j.1464-0597.2011.00448.x
]Search in Google Scholar
[
21. Davey J, Wishart D, Freeman J, Watson B. An application of the driver behaviour questionnaire in an Australian organisational fleet setting. Transport Res Part F Traffic Psychol Behav 2007; 10(1): 11-21.10.1016/j.trf.2006.03.001
]Search in Google Scholar
[
22. Poulter DR, Chapman P, Bibby PA, Clarke DD, Crundall D. An application of the theory of planned behaviour to truck driving behaviour and compliance with regulations. Accid Anal Prev 2008; 40(6): 2058-64.10.1016/j.aap.2008.09.00219068315
]Search in Google Scholar
[
23. Vearrier D, Vearrier L, McKeever R, Okaneku J, LaSala G, Goldberger D, McCloskey K. Issues in driving impairment. Dis Mon 2016; 62(4): 72-116.10.1016/j.disamonth.2016.02.00226997643
]Search in Google Scholar
[
24. Girotto E, Mesas AE, de Andrade SM, Birolim MM. Psychoactive substance use by truck drivers: a systematic review. Occup Environ Med 2014; 71(1): 71-6.10.1136/oemed-2013-101452388860224145953
]Search in Google Scholar
[
25. Girotto E, Guidoni CM, González AD, Mesas AE, Andrade SM. Continued use of drugs and working conditions among truck drivers. Cien Saude Colet 2016; 21(12): 3769-76.10.1590/1413-812320152112.2421201527925117
]Search in Google Scholar
[
26. Okamura K, Fujita G, Kihira M, Kosuge R. Patterns of use, knowledge, and perceived effects of sedating medication on driving: a questionnaire survey of Japanese drivers who use sedating medication. Transport Res Part F Traffic Psychol Behav 2018; 54: 276-89.10.1016/j.trf.2018.02.009
]Search in Google Scholar
[
27. Williamson A. Predictors of psychostimulant use by long-distance truck drivers. Am J Epidemiol 2007; 166(11): 1320-6.10.1093/aje/kwm20517716982
]Search in Google Scholar
[
28. Mir MU, Razzak JA, Ahmad K. Commercial vehicles and road safety in Pakistan: exploring high-risk attributes among drivers and vehicles. Int J Inj Contr Saf Promot 2013; 20(4): 331-8.10.1080/17457300.2012.73371323092513
]Search in Google Scholar
[
29. Couper FJ, Pemberton M, Jarvis A, Hughes M, Logan BK. Prevalence of drug use in commercial tractortrailer drivers. J Forensic Sci 2002; 47(3): 562-7.10.1520/JFS15296J
]Search in Google Scholar
[
30. Kagashe G, Seleman K. Knowledge, attitude and practice of commercial drivers in Dar es Salaam with regard to medicines that impair driving. Trop J Pharm Res 2009; 8(4): 297-302.10.4314/tjpr.v8i4.45220
]Search in Google Scholar
[
31. Monteiro SP, van Dijk L, Verstraete AG, Alvarez FJ, Heissing M, de Gier JJ. Predictor for patient knowledge and reported behaviors regarding driving under the influence of medicines: a multi-country survey. BMC Public Health 2012; 12: 59.10.1186/1471-2458-12-59329846122264358
]Search in Google Scholar
[
32. MacLennan PA, Owsley C, Rue LW, McGwin G. Older adults’ knowledge about medications that can impact driving Washington DC, United States of America: AAA foundation for traffic safety; 2009.
]Search in Google Scholar
[
33. Veldhuijzen DS, Van Wijck AJM, Verster JC, et al. The impact of patients’ psychotropic drug knowledge and warning labels on the decision whether to drive a car or not. Traffic Inj Prev 2006; 7(4): 360-4.10.1080/1538958060094300517114093
]Search in Google Scholar
[
34. DeVellis RF. Scale Development: Theory and Applications (Applied Social Research Methods), 3rd edition. London: SAGE publications; 2011.
]Search in Google Scholar
[
35. Ravera S, Monteiro SP, de Gier JJ, van der Linden T, Gómez-Talegón T, Alvarez FJ; DRUID Project WP4 Partners. A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project. Br J Clin Pharmacol 2012; 74(6): 920-31.10.1111/j.1365-2125.2012.04279.x352280522452358
]Search in Google Scholar
[
36. Fierro I, Gómez-Talegón T, Alvarez FJ. The Spanish pictogram on medicines and driving: The population’s comprehension of and attitudes towards its use on medication packaging. Accid Anal Prev 2013; 50: 1056-61.10.1016/j.aap.2012.08.00922944189
]Search in Google Scholar
[
37. Monteiro S, Huiskes R, van Dijk L, van Weert J, de Gier J. How effective are pictograms in communicating risk about driving-impairing medicines? Traffic Inj Prev 2013; 14(3): 299-308.
]Search in Google Scholar
[
38. Emich B, van Dijk L, Monteiro SP, de Gier JJ. A study comparing the effectiveness of three warning labels on the package of driving-impairing medicines. Int J Clin Pharm 2014; 36(6): 1152-9.10.1007/s11096-014-0010-225204257
]Search in Google Scholar
[
39. Smyth T, Sheehan M, Siskind V. Hospital outpatients’ responses to taking medications with driving warnings. Traff Inj Prev 2013; 14(1): 18-25.10.1080/15389588.2012.68422423259515
]Search in Google Scholar
[
40. Brooke BT, Southward RD. An audit on advice on fitness to drive during accident and Emergency Department attendance. Emerg Med J 2006; 23(2): 103-4.10.1136/emj.2004.020776256402616439736
]Search in Google Scholar
[
41. Laaksonen R, Duggan C, Bates I. Desire for information about drugs: relationships with patients’ characteristics and adverse effects. Pharm World Sci 2002; 24(5): 205-10.10.1023/A:1020542502118
]Search in Google Scholar
[
42. Legrand SA, Boets S, Meesmann U, Verstraete AG. Medicines and driving: evaluation of training and software support for patient counselling by pharmacists. Int J Clin Pharm 2012; 34(4): 633-43.10.1007/s11096-012-9658-722678812
]Search in Google Scholar
[
43. Elder RW, Shults RA, Sleet DA, Nichols JL, Thompson RS, Rajab W; Task Force on Community Preventive Services. Effectiveness of mass media campaigns for reducing drinking and driving and alcohol-involved crashes: a systematic review. Am J Prev Med 2004; 27(1): 57-65.10.1016/j.amepre.2004.03.00215212776
]Search in Google Scholar
[
44. Elayeh E, Bulatova N, Basheti I, Abu Farha R, Al-Rawi N, Abu Snaineh A,Alahwal I. The use and safety of medications known to affect driving in Jordan: A crosssectional study. Traffic Inj Prev 2016; 17(3): 238-44.10.1080/15389588.2015.106554326421446
]Search in Google Scholar
[
45. Labat L, Fontaine B, Delzenne C, Doublet A, Marek MC, Tellier D, Tonneau M,Lhermitte M, Frimat P. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France). Forensic Sci Int 2008; 174(2-3): 90-4.10.1016/j.forsciint.2007.03.00417418990
]Search in Google Scholar
[
46. Herrera-Gómez F, Gutierrez-Abejón E, Criado-Espegel P, Álvarez FJ. The Problem of Benzodiazepine Use and Its Extent in the Driver Population: A Population-Based Registry Study. Front Pharmacol 2018; 9: 408.10.3389/fphar.2018.00408593307829755352
]Search in Google Scholar
[
47. Drummer OH, Yap S. The involvement of prescribed drugs in road trauma. Forensic Sci Int 2016; 265: 17-21.10.1016/j.forsciint.2015.12.05026826848
]Search in Google Scholar
